Organogenesis Inc. (ORGO)
NASDAQ: ORGO
· Real-Time Price · USD
3.10
0.07 (2.31%)
At close: May 16, 2025, 3:59 PM
3.03
-2.39%
After-hours: May 16, 2025, 07:39 PM EDT
Organogenesis Revenue Breakdown
| Period Ending | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | Dec 31, 2018 |
|---|---|---|---|---|---|---|---|
| Advanced Wound care Revenue | 453.64M | 405.51M | 422.23M | 430.84M | 294.62M | 220.74M | 29.12M |
| Advanced Wound care Revenue Growth | +11.87% | -3.96% | -2.00% | +46.23% | +33.47% | +658.13% | n/a |
| Surgical and Sports Medicine Revenue | 28.4M | 27.63M | 28.66M | 37.22M | 43.67M | 40.24M | n/a |
| Surgical and Sports Medicine Revenue Growth | +2.82% | -3.61% | -22.99% | -14.78% | +8.54% | n/a | n/a |
Operating Expense Breakdown
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 | Dec 31, 2017 | Sep 30, 2017 | Jun 30, 2017 | Mar 31, 2017 | Dec 31, 2016 | Sep 30, 2016 | Jun 30, 2016 | Mar 31, 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selling, General, and Administrative Revenue | 72.51M | 73.86M | 71.8M | 76.54M | 66.15M | 53.13M | 64.22M | 70.32M | 73.83M | 68.29M | 79.33M | 72.61M | 63.58M | 67.25M | 62.37M | 62.35M | 58.23M | 53.22M | 51.15M | 46.5M | 52.61M | 52.37M | 49.48M | 48.96M | 48.89M | 47.48M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Selling, General, and Administrative Revenue Growth | -1.82% | +2.87% | -6.20% | +15.71% | +24.49% | -17.27% | -8.67% | -4.76% | +8.11% | -13.91% | +9.25% | +14.20% | -5.46% | +7.83% | +0.03% | +7.07% | +9.42% | +4.05% | +9.99% | -11.62% | +0.47% | +5.85% | +1.06% | +0.13% | +2.98% | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Research and Development Revenue | 10.64M | 11.53M | 10.34M | 15.59M | 12.81M | 11.77M | 10.47M | 10.94M | 11.2M | 11.39M | 9.57M | 10.21M | 8.59M | 8.26M | 8.95M | 7.32M | 6.21M | 6.3M | 3.71M | 4.67M | 5.41M | 3.64M | 3.92M | 3.86M | 3.37M | 3.09M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Research and Development Revenue Growth | -7.72% | +11.47% | -33.64% | +21.68% | +8.84% | +12.42% | -4.28% | -2.36% | -1.69% | +19.01% | -6.17% | +18.84% | +3.96% | -7.74% | +22.31% | +17.89% | -1.43% | +69.83% | -20.54% | -13.72% | +48.63% | -7.24% | +1.55% | +14.62% | +9.06% | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |